Ortivus AB (publ) (ORTI-B.ST)
SEK 1.48
(-6.62%)
SEK 1.48
(-6.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -18.24 Million SEK | -409.66% |
| 2022 | 5.89 Million SEK | -36.03% |
| 2021 | 9.21 Million SEK | -18.72% |
| 2020 | 11.33 Million SEK | 168.35% |
| 2019 | -16.58 Million SEK | -23.81% |
| 2018 | -13.39 Million SEK | -15.39% |
| 2017 | -11.6 Million SEK | -63.94% |
| 2016 | -7.07 Million SEK | 0.16% |
| 2015 | -7.09 Million SEK | -606.43% |
| 2014 | 1.4 Million SEK | 109.97% |
| 2013 | -14.04 Million SEK | -732.57% |
| 2012 | 2.22 Million SEK | 105.86% |
| 2011 | -37.86 Million SEK | -70.0% |
| 2010 | -22.27 Million SEK | -20.51% |
| 2009 | -18.48 Million SEK | 73.2% |
| 2008 | -68.94 Million SEK | -12.49% |
| 2007 | -61.28 Million SEK | 58.92% |
| 2006 | -149.18 Million SEK | -742.24% |
| 2005 | -17.71 Million SEK | -236.31% |
| 2004 | 12.99 Million SEK | 69.34% |
| 2003 | 7.67 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.15 Million SEK | 22.53% |
| 2024 Q2 | -8.33 Million SEK | -287.22% |
| 2023 Q3 | -10.9 Million SEK | -127.66% |
| 2023 Q1 | -38 Thousand SEK | -118.81% |
| 2023 FY | -18.24 Million SEK | -409.66% |
| 2023 Q4 | -2.77 Million SEK | 74.53% |
| 2023 Q2 | -4.79 Million SEK | -12505.26% |
| 2022 Q1 | 1.96 Million SEK | 18.3% |
| 2022 Q2 | 3.49 Million SEK | 77.86% |
| 2022 Q3 | 230 Thousand SEK | -93.42% |
| 2022 Q4 | 202 Thousand SEK | -12.17% |
| 2022 FY | 5.89 Million SEK | -36.03% |
| 2021 Q3 | 2.7 Million SEK | -13.73% |
| 2021 Q2 | 3.14 Million SEK | 84.71% |
| 2021 FY | 9.21 Million SEK | -18.72% |
| 2021 Q1 | 1.7 Million SEK | -22.41% |
| 2021 Q4 | 1.66 Million SEK | -38.69% |
| 2020 Q3 | 1.21 Million SEK | -82.36% |
| 2020 Q1 | 1.06 Million SEK | 158.58% |
| 2020 Q2 | 6.86 Million SEK | 544.51% |
| 2020 FY | 11.33 Million SEK | 168.35% |
| 2020 Q4 | 2.19 Million SEK | 80.92% |
| 2019 Q4 | -1.81 Million SEK | 47.14% |
| 2019 FY | -16.58 Million SEK | -23.81% |
| 2019 Q3 | -3.43 Million SEK | 27.16% |
| 2019 Q2 | -4.72 Million SEK | 21.67% |
| 2019 Q1 | -6.02 Million SEK | -53.32% |
| 2018 FY | -13.39 Million SEK | -15.39% |
| 2018 Q1 | -3.77 Million SEK | -79.38% |
| 2018 Q2 | -4.64 Million SEK | -23.07% |
| 2018 Q3 | -1.03 Million SEK | 77.71% |
| 2018 Q4 | -3.93 Million SEK | -279.44% |
| 2017 Q4 | -2.1 Million SEK | 45.52% |
| 2017 Q3 | -3.86 Million SEK | -24.6% |
| 2017 Q2 | -3.1 Million SEK | -22.28% |
| 2017 Q1 | -2.53 Million SEK | -348.87% |
| 2017 FY | -11.6 Million SEK | -63.94% |
| 2016 Q1 | -4.98 Million SEK | -159.26% |
| 2016 FY | -7.07 Million SEK | 0.16% |
| 2016 Q4 | 1.01 Million SEK | 1032.22% |
| 2016 Q3 | 90 Thousand SEK | 102.81% |
| 2016 Q2 | -3.2 Million SEK | 35.7% |
| 2015 Q2 | -119 Thousand SEK | -170.0% |
| 2015 Q3 | -5.21 Million SEK | -4284.87% |
| 2015 Q1 | 170 Thousand SEK | 104.5% |
| 2015 Q4 | -1.92 Million SEK | 63.17% |
| 2015 FY | -7.09 Million SEK | -606.43% |
| 2014 Q1 | 1.87 Million SEK | 127.06% |
| 2014 FY | 1.4 Million SEK | 109.97% |
| 2014 Q3 | 1.76 Million SEK | 13.7% |
| 2014 Q4 | -3.78 Million SEK | -314.77% |
| 2014 Q2 | 1.54 Million SEK | -17.31% |
| 2013 Q3 | -2.38 Million SEK | 18.19% |
| 2013 Q4 | -6.91 Million SEK | -189.66% |
| 2013 FY | -14.04 Million SEK | -732.57% |
| 2013 Q1 | -1.82 Million SEK | 3.75% |
| 2013 Q2 | -2.91 Million SEK | -60.38% |
| 2012 Q2 | 3.4 Million SEK | 212.92% |
| 2012 FY | 2.22 Million SEK | 105.86% |
| 2012 Q1 | -3.01 Million SEK | 75.04% |
| 2012 Q3 | 3.72 Million SEK | 9.15% |
| 2012 Q4 | -1.89 Million SEK | -150.82% |
| 2011 Q2 | -11.88 Million SEK | -142.54% |
| 2011 Q3 | -8.98 Million SEK | 24.36% |
| 2011 Q4 | -12.09 Million SEK | -34.56% |
| 2011 FY | -37.86 Million SEK | -70.0% |
| 2011 Q1 | -4.89 Million SEK | -12.31% |
| 2010 Q2 | -10.89 Million SEK | -6424.55% |
| 2010 Q3 | -6.96 Million SEK | 36.06% |
| 2010 FY | -22.27 Million SEK | -20.51% |
| 2010 Q4 | -4.36 Million SEK | 37.39% |
| 2010 Q1 | -167 Thousand SEK | 0.0% |
| 2009 FY | -18.48 Million SEK | 73.2% |
| 2008 FY | -68.94 Million SEK | -12.49% |
| 2007 FY | -61.28 Million SEK | 58.92% |
| 2006 FY | -149.18 Million SEK | -742.24% |
| 2005 FY | -17.71 Million SEK | -236.31% |
| 2004 FY | 12.99 Million SEK | 69.34% |
| 2003 FY | 7.67 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AddLife AB (publ) | 190 Million SEK | 109.603% |
| Biotage AB (publ) | 246 Million SEK | 107.417% |
| Bonesupport Holding AB (publ) | 245.02 Million SEK | 107.446% |
| Doxa AB (publ) | 291.9 Million SEK | 106.25% |
| Elekta AB (publ) | 1.3 Billion SEK | 101.401% |
| iZafe Group AB (publ) | -32.17 Million SEK | 43.294% |
| Ortivus AB (publ) | -18.24 Million SEK | -0.0% |
| Q-linea AB (publ) | -229.36 Million SEK | 92.045% |
| S2Medical AB (publ) | -22.7 Million SEK | 19.652% |
| Synsam AB (publ) | 311 Million SEK | 105.867% |